Cargando…

Got mutants? How advances in chlamydial genetics have furthered the study of effector proteins

Chlamydia trachomatis is the leading cause of infectious blindness and a sexually transmitted infection. All chlamydiae are obligate intracellular bacteria that replicate within a membrane-bound vacuole termed the inclusion. From the confines of the inclusion, the bacteria must interact with many ho...

Descripción completa

Detalles Bibliográficos
Autores principales: Andersen, Shelby E, Bulman, Lanci M, Steiert, Brianna, Faris, Robert, Weber, Mary M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862739/
https://www.ncbi.nlm.nih.gov/pubmed/33512479
http://dx.doi.org/10.1093/femspd/ftaa078
_version_ 1783647354359906304
author Andersen, Shelby E
Bulman, Lanci M
Steiert, Brianna
Faris, Robert
Weber, Mary M
author_facet Andersen, Shelby E
Bulman, Lanci M
Steiert, Brianna
Faris, Robert
Weber, Mary M
author_sort Andersen, Shelby E
collection PubMed
description Chlamydia trachomatis is the leading cause of infectious blindness and a sexually transmitted infection. All chlamydiae are obligate intracellular bacteria that replicate within a membrane-bound vacuole termed the inclusion. From the confines of the inclusion, the bacteria must interact with many host organelles to acquire key nutrients necessary for replication, all while promoting host cell viability and subverting host defense mechanisms. To achieve these feats, C. trachomatis delivers an arsenal of virulence factors into the eukaryotic cell via a type 3 secretion system (T3SS) that facilitates invasion, manipulation of host vesicular trafficking, subversion of host defense mechanisms and promotes bacteria egress at the conclusion of the developmental cycle. A subset of these proteins intercalate into the inclusion and are thus referred to as inclusion membrane proteins. Whereas others, referred to as conventional T3SS effectors, are released into the host cell where they localize to various eukaryotic organelles or remain in the cytosol. Here, we discuss the functions of T3SS effector proteins with a focus on how advances in chlamydial genetics have facilitated the identification and molecular characterization of these important factors.
format Online
Article
Text
id pubmed-7862739
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-78627392021-02-10 Got mutants? How advances in chlamydial genetics have furthered the study of effector proteins Andersen, Shelby E Bulman, Lanci M Steiert, Brianna Faris, Robert Weber, Mary M Pathog Dis Minireview Chlamydia trachomatis is the leading cause of infectious blindness and a sexually transmitted infection. All chlamydiae are obligate intracellular bacteria that replicate within a membrane-bound vacuole termed the inclusion. From the confines of the inclusion, the bacteria must interact with many host organelles to acquire key nutrients necessary for replication, all while promoting host cell viability and subverting host defense mechanisms. To achieve these feats, C. trachomatis delivers an arsenal of virulence factors into the eukaryotic cell via a type 3 secretion system (T3SS) that facilitates invasion, manipulation of host vesicular trafficking, subversion of host defense mechanisms and promotes bacteria egress at the conclusion of the developmental cycle. A subset of these proteins intercalate into the inclusion and are thus referred to as inclusion membrane proteins. Whereas others, referred to as conventional T3SS effectors, are released into the host cell where they localize to various eukaryotic organelles or remain in the cytosol. Here, we discuss the functions of T3SS effector proteins with a focus on how advances in chlamydial genetics have facilitated the identification and molecular characterization of these important factors. Oxford University Press 2021-01-29 /pmc/articles/PMC7862739/ /pubmed/33512479 http://dx.doi.org/10.1093/femspd/ftaa078 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of FEMS. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Minireview
Andersen, Shelby E
Bulman, Lanci M
Steiert, Brianna
Faris, Robert
Weber, Mary M
Got mutants? How advances in chlamydial genetics have furthered the study of effector proteins
title Got mutants? How advances in chlamydial genetics have furthered the study of effector proteins
title_full Got mutants? How advances in chlamydial genetics have furthered the study of effector proteins
title_fullStr Got mutants? How advances in chlamydial genetics have furthered the study of effector proteins
title_full_unstemmed Got mutants? How advances in chlamydial genetics have furthered the study of effector proteins
title_short Got mutants? How advances in chlamydial genetics have furthered the study of effector proteins
title_sort got mutants? how advances in chlamydial genetics have furthered the study of effector proteins
topic Minireview
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862739/
https://www.ncbi.nlm.nih.gov/pubmed/33512479
http://dx.doi.org/10.1093/femspd/ftaa078
work_keys_str_mv AT andersenshelbye gotmutantshowadvancesinchlamydialgeneticshavefurtheredthestudyofeffectorproteins
AT bulmanlancim gotmutantshowadvancesinchlamydialgeneticshavefurtheredthestudyofeffectorproteins
AT steiertbrianna gotmutantshowadvancesinchlamydialgeneticshavefurtheredthestudyofeffectorproteins
AT farisrobert gotmutantshowadvancesinchlamydialgeneticshavefurtheredthestudyofeffectorproteins
AT webermarym gotmutantshowadvancesinchlamydialgeneticshavefurtheredthestudyofeffectorproteins